Stryker Corp. CEO Stephen MacMillan ceded another pay raise last year, citing the “challenging business environment” and leaving the orthopedics giant’s top boss at 2008 base pay levels.
Stryker Corp. (NYSE: SYK ) CEO Stephen MacMillan once again deferred a pay raise in 2010 due to the “challenging business environment,” despite increasing the company’s bottom line by 15 percent last year.
The top boss at the Kalamazoo, Mich.-based orthopedic device maker earned $1.2 million in base salary for 2010, the same amount he took home in both 2008 and 2009, according to regulatory filings.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
But unlike the previous year, MacMillan took home a significant performance bonus of nearly $1.4 million, just shy of the maximum $1.8 million he could have pulled down. MacMillan received just $545,000 in performance bonuses in 2009, as Stryker saw profits slip by nearly 4 percent for the year.
Stryker’s performance bonuses are based on meeting sales, EPS, cash from operations and quality/compliance standards. In 2009, none of the officers at Stryker Corp. reached even 80 percent of their target bonuses.
MacMillan also fetched about $2 million in stock option awards and about $225,000 in other compensation, for a total of $4.7 million. Some of those perks included country club fees, an executive physical and personal use of the corporate jet.
Overall, Stryker closed out last year on a strong note, reporting profits of $1.27 billion, or $3.19 per diluted share, on $7.32 billion in sales. That’s a 15.5 percent top-line increase from earnings of $1.1 billion, or $2.79 per diluted share, on $6.7 billion in sales during 2009.
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
The Massachusetts Medical Devices Journal is the online journal of the medical devices industry in the Commonwealth and New England, providing day-to-day coverage of the devices that save lives, the people behind them, and the burgeoning trends and developments within the industry.
